FR1325M - Nouveaux aminoacétylenes. - Google Patents

Nouveaux aminoacétylenes.

Info

Publication number
FR1325M
FR1325M FR868440A FR868440A FR1325M FR 1325 M FR1325 M FR 1325M FR 868440 A FR868440 A FR 868440A FR 868440 A FR868440 A FR 868440A FR 1325 M FR1325 M FR 1325M
Authority
FR
France
Prior art keywords
aminoacetylenes
new
new aminoacetylenes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR868440A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mead Johnson and Co LLC
Original Assignee
Mead Johnson and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson and Co LLC filed Critical Mead Johnson and Co LLC
Application granted granted Critical
Publication of FR1325M publication Critical patent/FR1325M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
FR868440A 1960-07-26 1961-07-20 Nouveaux aminoacétylenes. Active FR1325M (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4529260A 1960-07-26 1960-07-26
US118261A US3176019A (en) 1960-07-26 1961-06-20 Substituted aminobutynyl acetates

Publications (1)

Publication Number Publication Date
FR1325M true FR1325M (fr) 1962-05-21

Family

ID=26722613

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868440A Active FR1325M (fr) 1960-07-26 1961-07-20 Nouveaux aminoacétylenes.

Country Status (9)

Country Link
US (1) US3176019A (fr)
BE (1) BE606560A (fr)
CH (1) CH421078A (fr)
DE (1) DE1216866B (fr)
DK (1) DK113854B (fr)
ES (1) ES269353A1 (fr)
FR (1) FR1325M (fr)
GB (1) GB940540A (fr)
NL (2) NL124473C (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736577A (en) * 1995-01-31 1998-04-07 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US3864388A (en) * 1970-12-29 1975-02-04 Sumitomo Chemical Co Alkynyl esters of {60 -alkoxy-{60 -phenyl alkenoic acid
US5036107A (en) * 1986-06-27 1991-07-30 Marion Merrell Dow Inc. 1,7-substituted heptyn-2-ones and use
US4957941A (en) * 1987-11-16 1990-09-18 United Pharmaceuticals, Inc. Anti-spasmdoic agents having an acetylenic bond
IL91377A (en) * 1988-09-14 1996-09-12 Nippon Shinyaku Co Ltd Derivatives of botinylamine glycolate
US5532278A (en) * 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5677346A (en) * 1995-01-31 1997-10-14 Sepracor, Inc. Treating urinary incontinence using (S)-desethyloxybutynin
WO1998001125A2 (fr) * 1996-07-09 1998-01-15 Sepracor, Inc. Isomeres dextrogyres d'oxybutynine et de desethyloxybutynine utilises dans le traitement de l'hyperactivite gastro-intestinale
US5973182A (en) * 1998-10-22 1999-10-26 Sepracor Inc. Carbonate Intermediates useful in the preparation of optically active cyclohexylphenylglycolate esters
US6140529A (en) * 1998-10-22 2000-10-31 Sepracor Inc. Synthesis of optically active cyclohexylphenylglycolate esters
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
CA2406064C (fr) * 2000-04-26 2011-03-15 Watson Pharmaceuticals, Inc. Reduction d'episodes indesirables associes a une therapie par l'oxybutynine
ATE418534T1 (de) 2001-10-26 2009-01-15 Pharmacia & Upjohn Co Llc Quaternäre ammoniumverbindungen und deren verwendung als antimuscarinische wirkstoffe
AU2002345266B2 (en) 2002-07-08 2009-07-02 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
EP1546098B1 (fr) * 2002-07-31 2008-05-28 Ranbaxy Laboratories Limited Derivés 3,6-disubstitués d'azabicyclo[3.1.0]hexane utilisés comme antagonistes des récepteurs muscariniques
AU2002321711A1 (en) * 2002-08-09 2004-02-25 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives useful as muscarinic receptor antagonist
AU2002326072A1 (en) * 2002-08-23 2004-03-11 Ranbaxy Laboratories Limited Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo (3.1.0) hexane derivatives as muscarinic receptor antagonists
TW200412945A (en) 2002-10-25 2004-08-01 Upjohn Co Quaternary ammonium compounds
WO2004052857A1 (fr) 2002-12-10 2004-06-24 Ranbaxy Laboratories Limited Derives d'azabicyclo [3.1.0] hexane 3,6-disubstitues utilises comme antagonistes du recepteur muscarinique
ATE386738T1 (de) * 2002-12-23 2008-03-15 Ranbaxy Lab Ltd Flavaxat-derivate als muscarin-rezeptor antagonisten
EP1583741A1 (fr) * 2002-12-23 2005-10-12 Ranbaxy Laboratories, Limited Derives de 1-substitues-3-pyrrolidines comme antagonistes de recepteurs muscariniques
US7488748B2 (en) 2003-01-28 2009-02-10 Ranbaxy Laboratories Limited 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
WO2004089898A1 (fr) * 2003-04-09 2004-10-21 Ranbaxy Laboratories Limited Derives d'azabicyclo hexane substitues en tant qu'antagonistes de recepteurs muscariniques
JP2006514978A (ja) * 2003-04-10 2006-05-18 ランバクシー ラボラトリーズ リミテッド ムスカリン受容体アンタゴニストである置換アザビシクロヘキサン誘導体
WO2004089899A1 (fr) 2003-04-10 2004-10-21 Ranbaxy Laboratories Limited Derives d’azabicyclo hexanes 3,6-disubstitues en tant qu’antagonistes des recepteurs muscariniques
WO2004089900A1 (fr) * 2003-04-11 2004-10-21 Ranbaxy Laboratories Limited Derives azabicyclo utiles comme antagonistes du recepteur muscarinique
EP1765809B1 (fr) * 2004-06-16 2008-12-31 Ranbaxy Laboratories Limited Derives de xanthine utilises en tant qu'antagonistes du recepteur muscarinique
WO2006018708A2 (fr) * 2004-08-19 2006-02-23 Ranbaxy Laboratories Limited Derives de pyrrolidine utilises en tant qu'antagonistes des recepteurs muscariniques
EP1794161A2 (fr) * 2004-09-24 2007-06-13 Ranbaxy Laboratories Limited Antagonistes des recepteurs muscariniques
WO2006035303A1 (fr) * 2004-09-29 2006-04-06 Ranbaxy Laboratories Limited Antagonistes de recepteurs muscariniques
EP1828174A1 (fr) * 2004-11-19 2007-09-05 Ranbaxy Laboratories Limited Antagonistes azabicycliques des recepteurs muscariniques
EP1828126A1 (fr) * 2004-12-15 2007-09-05 Ranbaxy Laboratories Limited Sels d'addition d'acide d'antagonistes du recepteur muscarinique
EP1888525A1 (fr) * 2005-05-03 2008-02-20 Ranbaxy Laboratories Limited Derives d'azabicyclo [3.1.0]hexane 3,6-disubstitues utilises comme antagonistes du recepteur muscarinique
BRPI0617674A2 (pt) 2005-10-19 2011-08-02 Ranbaxy Lab Ltd composições farmacêuticas e seus usos
US20090010923A1 (en) * 2007-04-24 2009-01-08 University Of Maryland, Baltimore Treatment of cancer with anti-muscarinic receptor agents
WO2009122429A2 (fr) * 2008-02-04 2009-10-08 Matrix Laboratories Limited Oxybutynine cristalline et son procédé de préparation
JP5812500B2 (ja) 2010-04-30 2015-11-17 メルク・シャープ・エンド・ドーム・コーポレイション 新規なβ３アドレナリン作動性受容体アゴニスト
US9907767B2 (en) 2010-08-03 2018-03-06 Velicept Therapeutics, Inc. Pharmaceutical compositions and the treatment of overactive bladder
EA030145B1 (ru) 2010-08-03 2018-06-29 Велисепт Терапьютикс, Инк. Комбинации агонистов бета-3-адренергических рецепторов и антагонистов мускариновых рецепторов для лечения гиперактивности мочевого пузыря
KR20150020160A (ko) 2012-02-09 2015-02-25 앨씨알엑스, 인크. 과민성 방광의 치료를 위한 무스카린 수용체 길항제 및 베타―3 아드레날린 수용체 작용제의 조합물
KR20170086659A (ko) 2014-12-03 2017-07-26 벨리셉트 테라퓨틱스, 인크. 하부 요로 증상을 위한 변형 방출형 솔라베그론을 이용한 조성물 및 방법
CN114230477A (zh) 2015-10-23 2022-03-25 B3Ar治疗股份有限公司 索拉贝隆两性离子及其应用
MX2020008086A (es) 2018-01-30 2021-02-15 Apnimed Inc Delaware Metodos y composiciones para tratar la apnea del sue?o.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE895595C (de) * 1943-09-29 1953-11-05 Basf Ag Verfahren zur Herstellung von Aminoalkinolen
DE1003209B (de) * 1953-03-24 1957-02-28 Basf Ag Verfahren zur Herstellung spasmolytisch wirksamer basischer Carbinole
US2867619A (en) * 1956-11-05 1959-01-06 Lakeside Lab Inc Aminoalkynyl-n-alkylpiperidine carboxylates
DE1083254B (de) * 1957-04-01 1960-06-15 Lakeside Lab In Verfahren zur Herstellung von blutdrucksenkenden N-disubstituierten Diaminoalkinen, deren Saeureadditionssalzen oder quaternaeren Ammoniumsalzen
DE1100617B (de) * 1959-10-22 1961-03-02 Basf Ag Verfahren zur Herstellung von 1-Dialkylamino-4-hydroxy-acetylenen-(2)

Also Published As

Publication number Publication date
ES269353A1 (es) 1961-11-16
NL124473C (fr)
NL267508A (fr)
DK113854B (da) 1969-05-05
DE1216866B (de) 1966-05-18
CH421078A (de) 1966-09-30
US3176019A (en) 1965-03-30
GB940540A (en) 1963-10-30
BE606560A (fr) 1962-01-26

Similar Documents

Publication Publication Date Title
FR1325M (fr) Nouveaux aminoacétylenes.
FR1417M (fr) 2-cyano-3-oxo-stéroides.
FR1376M (fr) Hydrindene-sulfonylurées.
DK104277C (da) Termokopieringsmaskine.
FR1165M (fr) α-pyrrolidino-acétophénones.
FR1566M (fr) 6α-16-méthylene-stéroides.
DK97274C (da) Murbor.
FR1290M (fr) 2-cyanostéroides.
FR1661M (fr) Nouveaux antibiotiques.
FR27M (fr) Nouveaux médicaments anti-hypokaliémiques.
FR192M (fr) Nouveaux acylaminophénols.
FR205M (fr) Nouveaux agents de contraste.
FR3F (fr) Nouveaux médicaments anti-hypokaliémiques.
BE595454R (fr) Emballages nouveaux.
BE589995R (fr) Elektrofotografisch materiaal.
DK93326C (da) Kantsaks.
FR1442M (fr) Sulfapyrimidines.
FR1639M (fr) N-halobenzyl-n-méthyl-2-propynylamines.
FR1319M (fr) Stéroide-3-énolacylés.
BE595201R (fr) Binnenscheepvaartschroef.
FR1282M (fr) Sulfapyrimidines.
FR1167M (fr) α-pyrrolidino-propio-phénones.
BE589994R (fr) Elektrofotografisch materiaal.
BE600923R (fr) Diazotypmateriaal.
DK99961C (da) Ostereol.